These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 20575288

  • 1. [Clinical research of electroacupuncture combined with acupoint-injection of botulinum toxin A in treating the muscle spasticity by spinal cord injury].
    Xing ST, Wang D, Wen XH, Wu ZQ, Sun Q, Zhang DW, Cheng Y, Yan D, Yu F.
    Zhongguo Gu Shang; 2010 May; 23(5):350-3. PubMed ID: 20575288
    [Abstract] [Full Text] [Related]

  • 2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 May; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 3. [Botulinum toxin A (BTX-A) point injection for treatment of the third lumbar transverse process syndrome].
    Liu Z.
    Zhongguo Zhen Jiu; 2008 May; 28(5):337-9. PubMed ID: 18652324
    [Abstract] [Full Text] [Related]

  • 4. Repeated botulinum toxin injections can improve mobility in patients with spinal cord lesions.
    Catz A, Barkol H, Steinberg F, Ronen J, Bluvshtein V, Keren O.
    Eura Medicophys; 2007 Sep; 43(3):319-25. PubMed ID: 17525702
    [Abstract] [Full Text] [Related]

  • 5. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu, Tiebin Yan, Jianning Mai.
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F, Sandrini G, Moglia A, Nappi G, Pacchetti C.
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A.
    Guettard E, Roze E, Abada G, Lemesle C, Vidailhet M, Laurent-Vannier A, Chevignard MP.
    Dev Neurorehabil; 2009 Jun; 12(3):128-38. PubMed ID: 19466620
    [Abstract] [Full Text] [Related]

  • 20. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
    Suputtitada A, Suwanwela NC.
    Disabil Rehabil; 2005 Feb 18; 27(4):176-84. PubMed ID: 15824048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.